[1]
Luk, K.J. et al. 2024. UNDERPRESCRIPTION OF SGLT2i IN TYPE 2 DIABETES PATIENTS WITH CARDIORENAL DISEASE IN A PUBLICLY FUNDED TERTIARY CENTER IN MALAYSIA. Journal of the ASEAN Federation of Endocrine Societies. 39, S1 (Jul. 2024), 39.